Method for prophylaxis of influenza using vaccine for intranasal administration

Details for Australian Patent Application No. 2010232180 (hide)

Owner THE RESEARCH FOUNDATION FOR MICROBIAL DISEASES OF OSAKA UNIVERSITY TOKO YAKUHIN KOGYO KABUSHIKI KAISHA JAPAN AS REPRESENTED BY THE DIRECTOR-GENERAL OF NATIONAL INSTITUTE OF INFECTIOUS DISEASES

Inventors Hasegawa, Hideki; Manabe, Sadao; Tanimoto, Takeshi; Miyazaki, Takashi; Kamishita, Taizou

Agent Griffith Hack

Pub. Number AU-A-2010232180

PCT Pub. Number WO2010/114169

Priority 61/165,098 31.03.09 US

Filing date 31 March 2010

Wipo publication date 7 October 2010

International Classifications

C07K 14/11 (2006.01) Peptides having more than 20 amino acids

A61K 39/145 (2006.01) Medicinal preparations containing antigens or antibodies - Orthomyxoviridae, e.g. influenza virus

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

Event Publications

3 November 2011 PCT application entered the National Phase

  PCT publication WO2010/114169 Priority application(s): WO2010/114169

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010232202-Monoclonal antibody capable of binding to specific discontinuous epitope occurring in AD1 region of human cytomegalovirus gB glycoprotein, and antigenbinding fragment thereof

2010232165-Developer replenishing container and developer replenishing system